Physician profile
Sujoy Phookan
NPI 1245625391
$5,746.36
in general payments reported to CMS, 2019-2025
16 companies · $2,294 in 2025
The $2,294 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.93 · 2021: $1,889 · 2022: $1,027 · 2023: $325 · 2024: $180 · 2025: $2,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,487 · Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,486.92 |
| Food and Beverage | $1,312.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,389.76 | 2019-2025 | Xience Skypoint, Cardiomems, Optis |
| Boston Scientific Corporation | $630.97 | 2021-2025 | Rotapro, Embold Fibered |
| Edwards Lifesciences Corporation | $619.41 | 2021 | |
| Cardiovascular Systems INC. | $604.36 | 2021-2022 | |
| Abiomed | $591.07 | 2022-2023 | Impella |
| Medtronic, INC. | $337.45 | 2021-2023 | Onyx Frontier |
| Chiesi USA, INC. | $147.94 | 2021-2023 | Cleviprex, Kengreal |
| Philips North America LLC | $140.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $62.44 | 2021-2025 | Brilinta |
| Pfizer INC. | $53.05 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $45.11 | 2023 | Artis Icono Floor |
| Amgen INC. | $41.75 | 2024-2025 | Repatha, Repatha |
| Teleflex LLC | $24.55 | 2025 | Turnpike |
| Merck Sharp & Dohme LLC | $20.95 | 2023 | Verquvo |
| Angiodynamics, INC. | $19.36 | 2023 | Auryon Laser System 100-120 Vac |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.63 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujoy Phookan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.